Funded Tech Companies
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical growth company, located in Waltham. Financial backing was provided by Takeda Ventures, Deerfield Capital and Atlas Venture.
Company Overview
Company Name
Xilio Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
828 Winter St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company's proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body -- a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/22/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rene Russo
Chief Medical Officer
Marty Huber
Chief Operating Officer
Joseph Farmer
President
Timothy Clackson
VP - R & D
Ronan O'Hagan
Company Investors
- Takeda Ventures (Jayson Punwani)
- Deerfield Capital
- Atlas Venture (David Grayzel)
- Rock Springs Capital (David Gardner)
- Bain Capital Life Sciences
- MRL Ventures (Peter Dudek)
- SV Health Investors (Michael Ross)
- RiverVest Venture Partners (Nancy Hong)
- RA Capital
- Ipsen
- M Capital
- Bay City Capital
- F-Prime Capital (Benjamin Auspitz)
- Solasta Ventures
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs